Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis

Bochuan Deng(Lanzhou University), Junqiu Xie(Sun Yat-sen University), Lu Cheng(Tianjin Medical University General Hospital), Liang Hong(Sun Yat-sen University), Guangjun Bao(Lanzhou University), Ping Su(Lanzhou University), Guofeng Li(Shenzhen University), Dan Wang(First Affiliated Hospital of Zhengzhou University), Rui Wang(University of South China), Xiang Zhang(Lanzhou University), Jiao Zhang(Lanzhou University), Xiaokang Miao(Lanzhou University), Tingli Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenle Yang(Lanzhou University)
ACS Pharmacology & Translational Science
March 14, 2024
Cited by 3


Related Papers